Drugs / Epinephrine injection
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07392580 Background | Sep 2026 → Sep 2031 expected | laryngeal squamous cell carcinoma | University of Miami | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epinephrine injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07392580 ↗ |
| Route | Other | “via intralesional injection” NCT07392580 ↗ |